Ajay K. Agrawal
Corporate Officer/Principal chez Almac Sciences Group Ltd.
Profil
Dr. Ajay K.
Agrawal is Director-Business Development at Almac Sciences Group Ltd.
and Independent Non-Executive Director at ImmuPharma Plc.
He is on the Board of Directors at Ecron Acunova GmbH and ImmuPharma Plc.
Dr. Agrawal was previously employed as Director-Business Development by Xenetic Biosciences Plc.
He received his doctorate degree from the University of Alberta.
Postes actifs de Ajay K. Agrawal
| Sociétés | Poste | Début |
|---|---|---|
| Almac Sciences Group Ltd. | Corporate Officer/Principal | - |
Anciens postes connus de Ajay K. Agrawal
| Sociétés | Poste | Fin |
|---|---|---|
| IMMUPHARMA PLC | Directeur/Membre du Conseil | 23/10/2015 |
Navitas Life Sciences GmbH
 Navitas Life Sciences GmbH Miscellaneous Commercial ServicesCommercial Services Part of TAKE Solutions Ltd., Navitas Life Sciences GmbH is a technology-enabled clinical research organization (CRO) providing outsourced data science, regulatory & safety and full-service CRO services. The company is based in Frankfurt, Germany. The German company was founded in 2007 by Achuta Rao Prasanna Dodballapur. The CEO is Harikesavanallur R. Srinivasan. | Directeur/Membre du Conseil | - |
Xenetic Biosciences (UK) Ltd.
 Xenetic Biosciences (UK) Ltd. Pharmaceuticals: MajorHealth Technology Xenetic Biosciences (UK) Ltd. is engaged in the development of drug and vaccine delivery systems and proprietary products in the fields of protein drugs, vaccines and oncology. It provides specialist delivery solutions to improve the efficacy and performance of drugs and vaccines in a number of key medical areas including oncology. The company's product pipeline includes polyxen, imuxen and oncohist. Xenetic Biosciences was founded by Gregory Gregoriadis on June 24, 1996 and is headquartered in London, the United Kingdom. | Corporate Officer/Principal | - |
Formation de Ajay K. Agrawal
| University of Alberta | Doctorate Degree |
Expériences
Fonctions occupées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| IMMUPHARMA PLC | Health Technology |
| Entreprise privées | 3 |
|---|---|
Xenetic Biosciences (UK) Ltd.
Xenetic Biosciences (UK) Ltd. Pharmaceuticals: MajorHealth Technology Xenetic Biosciences (UK) Ltd. is engaged in the development of drug and vaccine delivery systems and proprietary products in the fields of protein drugs, vaccines and oncology. It provides specialist delivery solutions to improve the efficacy and performance of drugs and vaccines in a number of key medical areas including oncology. The company's product pipeline includes polyxen, imuxen and oncohist. Xenetic Biosciences was founded by Gregory Gregoriadis on June 24, 1996 and is headquartered in London, the United Kingdom. | Health Technology |
Navitas Life Sciences GmbH
Navitas Life Sciences GmbH Miscellaneous Commercial ServicesCommercial Services Part of TAKE Solutions Ltd., Navitas Life Sciences GmbH is a technology-enabled clinical research organization (CRO) providing outsourced data science, regulatory & safety and full-service CRO services. The company is based in Frankfurt, Germany. The German company was founded in 2007 by Achuta Rao Prasanna Dodballapur. The CEO is Harikesavanallur R. Srinivasan. | Commercial Services |
| Almac Sciences Group Ltd. |
